GlassScriptPhysician profile
Grace A Pilcher
NPI 1245200203
$13,967.84
in general payments reported to CMS, 2019-2025
63 companies · $3,429 in 2025
The $3,429 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $420 · 2021: $971 · 2022: $2,425 · 2023: $2,418 · 2024: $3,428 · 2025: $3,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,274.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,755.54 | 2021-2025 | |
| Ucb, INC. | $823.01 | 2019-2025 | Briviact, Zilbrysq, Nayzilam |
| Novartis Pharmaceuticals Corporation | $815.00 | 2019-2025 | |
| Amgen INC. | $714.55 | 2019-2025 | Uplizna |
| Lundbeck LLC | $671.28 | 2021-2025 | Vyepti, Rexulti |
| Mdd US Operations, LLC | $628.21 | 2022-2024 | Gocovri, Gocovri |
| Teva Pharmaceuticals USA, INC. | $611.50 | 2019-2024 | Ajovy, Austedo Xr, Austedo |
| Astrazeneca Pharmaceuticals LP | $564.37 | 2019-2025 | Wainua, Airsupra, Breztri |
| Emd Serono, INC. | $523.98 | 2019-2025 | Mavenclad |
| Alexion Pharmaceuticals, INC. | $508.85 | 2019-2025 | Ultomiris |
| Sk Life Science, INC. | $444.80 | 2022-2025 | Xcopri |
| Otsuka America Pharmaceutical, INC. | $393.48 | 2023-2025 | Rexulti |
| Pfizer INC. | $387.34 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $386.83 | 2022-2025 | Ingrezza |
| Argenx US, INC. | $353.36 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Pilcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.